Anstee QM - Search Results

1

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.

Labenz C, Huber Y, Kalliga E, Nagel M, Ruckes C, Straub BK, Galle PR, Wörns MA, Anstee QM, Schuppan D, Schattenberg JM. Labenz C, et al. Among authors: anstee qm. Aliment Pharmacol Ther. 2018 Nov;48(10):1109-1116. doi: 10.1111/apt.14976. Epub 2018 Oct 4. Aliment Pharmacol Ther. 2018. PMID: 30288767

2

Genetics of alcoholic and nonalcoholic fatty liver disease.

Anstee QM, Daly AK, Day CP. Anstee QM, et al. Semin Liver Dis. 2011 May;31(2):128-46. doi: 10.1055/s-0031-1276643. Epub 2011 May 2. Semin Liver Dis. 2011. PMID: 21538280 Review.

3

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.

Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, Daly AK. Al-Serri A, et al. Among authors: anstee qm. J Hepatol. 2012 Feb;56(2):448-54. doi: 10.1016/j.jhep.2011.05.029. Epub 2011 Jul 12. J Hepatol. 2012. PMID: 21756849

4

How big a problem is non-alcoholic fatty liver disease?

Anstee QM, McPherson S, Day CP. Anstee QM, et al. BMJ. 2011 Jul 18;343:d3897. doi: 10.1136/bmj.d3897. BMJ. 2011. PMID: 21768191 No abstract available.

5

Genetic modifiers of non-alcoholic fatty liver disease progression.

Anstee QM, Daly AK, Day CP. Anstee QM, et al. Biochim Biophys Acta. 2011 Nov;1812(11):1557-66. doi: 10.1016/j.bbadis.2011.07.017. Epub 2011 Aug 5. Biochim Biophys Acta. 2011. PMID: 21840395 Free article. Review.

6

Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease.

Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, Taylor R, Day CP, Trenell MI. Hallsworth K, et al. Among authors: anstee qm. J Hepatol. 2013 Apr;58(4):757-62. doi: 10.1016/j.jhep.2012.11.015. Epub 2012 Nov 22. J Hepatol. 2013. PMID: 23178979

7

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

McPherson S, Anstee QM, Henderson E, Day CP, Burt AD. McPherson S, et al. Among authors: anstee qm. Eur J Gastroenterol Hepatol. 2013 Jun;25(6):652-8. doi: 10.1097/MEG.0b013e32835d72cf. Eur J Gastroenterol Hepatol. 2013. PMID: 23325287

8

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Anstee QM, Targher G, Day CP. Anstee QM, et al. Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23507799 Review.

9

Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.

Dyson JK, McPherson S, Anstee QM. Dyson JK, et al. Among authors: anstee qm. J Clin Pathol. 2013 Dec;66(12):1033-45. doi: 10.1136/jclinpath-2013-201620. Epub 2013 Aug 12. J Clin Pathol. 2013. PMID: 23940130 Review.

10

Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Henderson E, Burt AD, Day CP, Anstee QM. McPherson S, et al. Among authors: anstee qm. J Hepatol. 2014 May;60(5):1055-62. doi: 10.1016/j.jhep.2014.01.010. Epub 2014 Jan 18. J Hepatol. 2014. PMID: 24445215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters